Thursday, November 19, 2026

Immunisation: Stakeholders move to sustain BOOST gains in Lagos, Kano States


By Admin


With donor-supported health interventions often facing sustainability questions after project funding ends, stakeholders in Lagos and Kano States are examining how to preserve gains in immunisation advocacy, accountability and governance as the GSK/Save the Children International BOOST Project moves towards transition.

The concern dominated discussions at the BOOST Project organized Lessons Learning and Transition Planning Workshop held  November 16 to 20, 2026, at Hawthorn Suites, Abuja, where participants explored how successful interventions could be transferred into government structures, sustained through local resources and integrated into routine immunisation programmes.

The workshop brought together representatives of the Federal Ministry of Health, National Primary Health Care Development Agency, Lagos and Kano State Ministries of Health, State Primary Health Care Boards, Lagos State Accountability Mechanism for Maternal, Newborn, Child, Adolescent Health & Nutrition (LASAM), Kano's accountability and advocacy platform, Kano Community of Practice (KCoP), civil society and advocacy organisations, Save the Children International and technical consultants.

For participants of the two states, the impending transition raised an important question: can the accountability platforms, advocacy networks and policy engagement mechanisms strengthened through the BOOST project, continue to function effectively without depending on external project support?

A major highlight on Day 4, tagged "Experience Sharing and Lesson Learning",  provided an opportunity for participants from both states to compare experiences and examine government ownership of immunisation legal and policy frameworks.

Discussions focused on how government institutions could assume greater responsibility for policies, advocacy structures and accountability mechanisms established or strengthened through BOOST interventions.

Participants also held breakout sessions on stakeholder participation and advocacy, while working groups reviewed advocacy briefs designed to strengthen immunisation coordination, accountability and government engagement.

The exercise went beyond documenting successes. It also examined political and economic factors affecting universal immunisation coverage, stakeholder contributions, implementation gaps and the challenges of mobilising resources for sustained immunisation programmes.

Of particular importance was the need to ensure that advocacy and accountability platforms do not become inactive when project funding and technical support are withdrawn. Their continued relevance, participants recognised, depends on government commitment, institutional backing, adequate financing and active participation by civil society and communities.

The workshop reviewed lessons from BOOST-supported coordination, policy formulation, community engagement, resource mobilisation and accountability interventions. Participants examined the effectiveness of advocacy products and tools and explored ways to improve acceptance and implementation of immunisation-related policies and legislation.

A major expected deliverable from the transition planning process was a sustainability action plan expected to define responsibilities, timelines and follow-up mechanisms for government institutions, partners and advocacy groups at state, local government and community levels.

The plan is also expected to identify interventions requiring adoption, wider dissemination, institutionalisation or scale-up, with recommendations for resource mobilisation and continued stakeholder engagement.

For Lagos, the experience offers an opportunity to consolidate the work of LASAM and strengthen its role in holding government institutions accountable for immunisation commitments. Kano's experience similarly provides lessons on sustaining state-level coordination and advocacy structures.

Beyond the two states, the discussions highlight a wider challenge for Nigeria's immunisation programme: ensuring that investments in advocacy, governance and community engagement translate into lasting institutional capacity rather than temporary project achievements.

It was agreed that by consensus that the ultimate test of the BOOST transition will not simply be the number of interventions documented or recommendations produced, but whether state governments and local stakeholders can finance, own and sustain the structures and practices that support immunisation coverage long after the project ends.

ASF France faults Ojukwu’s detention, seeks Cybercrime Act review



By David Comixx


Avocats Sans Frontières France (ASF France) has called for the unconditional release of investigative journalist Daniel Ojukwu, warning that the continued use of Nigeria’s Cybercrimes Act to prosecute journalists over their reporting poses a threat to press freedom and public accountability.

The organisation said Ojukwu, a journalist with the Foundation for Investigative Journalism (FIJ), was remanded at the Kuje Correctional Centre on November 10, 2026, pending the hearing of his bail application over allegations of cyberstalking under the Cybercrimes Act and criminal defamation.

In a statement issued in Abuja on November 17, ASF France expressed concern over his continued detention, insisting that pre-trial detention should remain an exception, particularly in cases involving alleged non-capital offences.

While acknowledging the independence of the judiciary and the presumption of innocence, the organisation said the journalist's case reflected a wider pattern of using criminal laws to intimidate journalists, bloggers and other citizens over information published online.

It specifically faulted the repeated invocation of Section 24 of the Cybercrimes Act, noting that despite efforts to address concerns surrounding the provision, its application against journalists had continued.

According to ASF France, the Economic Community of West African States (ECOWAS) Court of Justice ordered Nigeria in 2022 to amend Section 24 to bring it in line with its human rights obligations. Although the provision was subsequently narrowed in 2024, the organisation said its use against the media remained a source of concern.

It warned that a law originally designed to tackle genuine cybercrime was increasingly being used to restrict legitimate journalism and public debate, creating a climate of fear that could discourage journalists from holding public officials accountable.

"Reporting on how public resources are managed is a service to society, not a threat to it," the organisation stated.

ASF France stressed that freedom of expression and the press were guaranteed under Section 39 of the Nigerian Constitution, Article 9 of the African Charter on Human and Peoples' Rights and Article 19 of the International Covenant on Civil and Political Rights.

It also drew attention to Article 9 of the International Covenant, which guarantees the right to liberty and security of the person.

The organisation further cited the African Commission on Human and Peoples' Rights' Declaration of Principles on Freedom of Expression and Access to Information in Africa, which calls on governments to repeal criminal defamation laws.

It argued that disputes arising from published reports should be resolved through civil remedies, including the right of reply, corrections or civil proceedings, rather than arrest and imprisonment.

Consequently, ASF France called on the Nigerian authorities to secure Ojukwu's unconditional release, decriminalise defamation and review the Cybercrimes Act to ensure full compliance with the country's regional and international human rights obligations.

The organisation said it was monitoring the implementation of the Cybercrimes Act through its EXPRESS project, supported by the Embassy of the Netherlands in Nigeria.

The project focuses on protecting freedom of expression and monitoring the application of the law in the Federal Capital Territory, Lagos and Enugu, while gathering evidence on its practical implications for human rights.

ASF France said it would continue to follow Ojukwu's case and expressed readiness to work with government authorities, the judiciary, media organisations and civil society groups to ensure that laws designed to protect people online do not become instruments for silencing those who keep the public informed.

AMR: Global experts worry over rising antibiotic use, seek urgent action to avert superbug crisis


By Sola Charles 

With antibiotic use in livestock projected to rise by nearly 30 per cent by 2040, global health experts have warned that antimicrobial resistance (AMR) could become an even greater threat to human survival, food security and the environment unless governments move beyond policy commitments to urgent, coordinated action.

The experts warned that the growing misuse and overuse of antimicrobials, coupled with poor infection prevention, environmental pollution, weak surveillance and inadequate regulation, are accelerating the emergence and spread of drug-resistant infections that could undermine decades of medical and agricultural progress.

They called for governments to strengthen national AMR action plans, invest in surveillance and laboratory systems, regulate antimicrobial use in humans, animals and agriculture, and tackle pollution from pharmaceutical manufacturing, healthcare facilities and municipal wastewater systems.

The warning comes ahead of the 2026 World AMR Awareness Week (WAAW) November 18 to 24, with the theme, “One Health, One Action: Prevent AMR Now.”

Director (a.i.) of the Antimicrobial Resistance Department of the World Health Organisation (WHO) and Director of the Quadripartite Joint Secretariat on AMR, Dr Jean-Pierre Nyemazi, said: “AMR is one of the most urgent global health threats and development challenges. It threatens our ability to treat infections, protect animal and plant health, and produce safe food, and also has an impact on the environment.

“In 2021, bacterial AMR alone was associated with more than 4.7 million deaths, these are not just statistics, behind these numbers are patients, families, farmers and communities.

“AMR does not recognize borders or sectors. It is driven by the misuse and overuse of antimicrobials. It is also driven by gaps in infection prevention and control, poor water and sanitation, and contamination in the environment. Action in one sector affects all others,” Nyemazi said.

He said world leaders had already made commitments at the 2024 United Nations General Assembly High-Level Meeting on AMR, including a target to reduce deaths associated with bacterial AMR by 10 per cent by 2030, against the 2019 baseline of 4.95 million deaths.

Countries also committed to ensuring that at least 60 per cent had funded national action plans on AMR, alongside mobilisation of at least $100 million in catalytic funding to support implementation.

“However, let’s be honest. The gap between commitments and pledges versus implementation remains wide. Many countries face limited financing, fragmented coordination across sectors, and also weak surveillance and data systems, in addition to poor access or inappropriate use of antimicrobials across all the sectors,” he said.

Nyemazi disclosed that an updated Global Action Plan on AMR, covering 2026 to 2036, had been finalised to guide the next decade of interventions.

He also announced that the Fifth Global High-Level Ministerial Conference on AMR would hold in Abuja, Nigeria, from December 6 to 8, 2026, under the theme, “One Health: Advancing Global AMR Commitments through Local Action.”

The conference is expected to review global progress, address implementation gaps and renew political commitment, while the proposed Independent Panel on Evidence for Action against AMR is also expected to be launched.


Livestock antibiotics could rise 30%

Reinforcing the warning, Deputy Chief Veterinarian and Chief of the One Health and Disease Control Branch at the Food and Agriculture Organisation of the United Nations (FAO), Dr Junxia Song, said the agri-food sector must become a central part of the global response, warning that rising antibiotic consumption in livestock could worsen the resistance crisis.

"The urgency is clear. FAO’s recent study, ‘The Future of Antibiotics Use in Livestock,’ shows that without action, global antibiotic use in livestock could increase by nearly 30 percent by 2040. But with good practices on better animal health and better practices on farm management, antibiotic use could be reduced up to 57 percent. This is the power of prevention.

“We must reduce the need for antibiotics while ensuring effective antimicrobials remain available and are used responsibly when treatment is necessary,” she said.

Song said FAO's 2026 to 2036 AMR roadmap would translate global commitments into practical interventions across the agri-food system, with emphasis on stronger national action plans, prevention, surveillance, laboratory capacity and sustainable financing.

She, however, identified inadequate integration of agricultural priorities into national AMR plans as a major weakness, noting that nearly half of countries had either no legislation or only partial legislation governing antimicrobial use in animal and plant health.

According to her, farmers must be placed at the centre of the response through FAO's 10-year initiative, Reduce the Need for Antimicrobials on Farms (RENOFARM).

The initiative is built around five interconnected areas: good health services, good production practices, good alternatives and innovation, good incentives and good connections, collectively described as the 5G farm approach.

“Better data can help countries understand their national situation, strengthen policies and regulations, and direct limited resources where they can have the greatest impact.

“Awareness and commitments are important, but they are not enough. Countries and farmers need stronger services, incentives, financing and capacity. So, our solutions must be practical, affordable and rewarding for farmers,” she noted.

Pollution is fuelling resistance

Adding an environmental dimension to the warning, AMR Coordinator, Chemicals and Health Branch, United Nations Environment Programme (UNEP), Aitziber Echeverria, cautioned that efforts to tackle drug resistance would remain incomplete if governments continued to treat it exclusively as a human health and agricultural problem.

She said the environment plays a significant role in the emergence, transmission and spread of antimicrobial resistance, with antimicrobial residues, resistant microorganisms and resistance genes entering ecosystems through pollution.

“AMR is often discussed as a public health and agriculture challenge — which of course it is, and a major one — but it is an environmental issue too,” she said.

Referring to UNEP's report, Bracing for Superbugs: Strengthening Environmental Action in the One Health Response, Echeverria said the environmental dimension of AMR must be addressed as an integral part of the global response.

According to her, pharmaceutical manufacturing must reduce the discharge of antimicrobial residues, while more sustainable agricultural practices can limit pollution from animal and crop production.

Healthcare facilities also need stronger antimicrobial stewardship, while municipal authorities must address untreated or inadequately treated waste and wastewater that can create conditions for resistance to emerge and spread.

She said preventing pollution at its source was critical, warning that environmental contamination could undermine gains made through interventions in human and animal health.

“All this brings us to stress that the most urgent action is prevention. We need to reduce the release of antimicrobial residues, resistant microorganisms and genes into the environment before they become a challenge. This means tackling pollution at its source — upstream,” she said.

Echeverria described the December 2025 adoption of a United Nations Environment Assembly resolution on the environmental dimensions of AMR as a significant milestone, but stressed that countries must now translate policy recognition into funded interventions.

She called for stronger environmental monitoring and surveillance systems, explaining that environmental data could help identify AMR hotspots and sources of contamination before they become more serious threats.

She also urged governments to formally include environmental authorities and institutions in national AMR governance structures rather than treating them as peripheral stakeholders.

“Environmental action on AMR is not an optional addition to the response. It is a prerequisite for success in addressing AMR with One Health approach. If we do not address the environmental dimensions of AMR, we risk undermining efforts in human and animal health.”

Stronger political commitment 

On his part, Dr Kefas Samson, Senior Technical Officer and Lead of Multisectoral Coordination, AMR Department, World Health Organisation (WHO) headquarters, said although political commitment had strengthened considerably, countries were still struggling with the resources and systems needed to deliver results.

Samson said the WHO, through the Quadripartite Joint Secretariat on AMR, was working with the Food and Agriculture Organisation (FAO), United Nations Environment Programme (UNEP) and World Organisation for Animal Health (WOAH) to help countries translate global commitments into practical interventions.

He said: “In terms of priorities and implementation gaps for WHO: evidently, to ensure that countries can effectively translate these global commitments into action, the focus of WHO is also on ensuring that these countries are able to assess their needs, prioritize and cost their interventions, and tailor implementations to their local realities and available resources as well.”

He identified inadequate financing, weak nationwide surveillance, poor diagnostic capacity and limited access to quality-assured antimicrobials as major obstacles slowing progress.

“Significant gaps still persist, and progress among countries also remains uneven. Notable among those challenges include inadequate financing to actually support the desired level of acceleration of implementation; gaps in nationwide implementation of AMR and antimicrobial use surveillance; as well as in the institution of preventive measures, particularly in healthcare facilities.

“There is also the issue of inadequate diagnostic capacity to support treatment decisions, as well as gaps in access to quality-assured antimicrobials, which is really a key issue. These gaps are also compounded by shortage of healthcare workforce, just like in other sectors, and inequitable access to the products that are required to support clinical activities.”

Beyond hospitals and specialist health facilities, Samson said primary healthcare and community-based services must become central to the AMR response, particularly in preventing infections, promoting behavioural change, improving early diagnosis and ensuring appropriate treatment.

“The Global Action Plan on AMR 2026-2036 provides a renewed blueprint for accelerating the implementation of actions to address the AMR issue but also being more measurable in terms of how impact and outcomes are intended to be measured. It is not just a plan now; but a framework that translates the aspirations and ambitions of the political declaration on AMR 2024 into tangible actions at the country level.”

Significant economic losses

Dr Jane Lwoyero, Programme Officer, WOAH, 
 disclosed that animal diseases account for losses estimated at up to $300 billion annually, much of which could be reduced through preventive measures, including vaccination, farm biosecurity, early detection and rapid response.

Despite the importance of vaccination, Lwoyero said fewer than 20 per cent of WOAH Member Countries vaccinate animals against notifiable diseases, but said WOAH had established an ad hoc animal health group, PROEVA, to identify priority animal diseases for which vaccines could reduce the need for antibiotics in pigs, poultry and fish.

On antimicrobial consumption, Lwoyero warned that the continued use of antibiotics for growth promotion remained a major concern. According to her, countries that permit the practice tend to use 45 per cent more antimicrobials than those that do not.

She said: “74 percent countries do not use antimicrobial growth promoters, 19 percent report using them, and 7 percent do not report but are still unknown regarding using antimicrobials for growth promotion, noting that WOAH was encouraging countries to discontinue the practice, stressing that antibiotics should not be used to compensate for poor animal husbandry, inadequate farm hygiene or weak disease prevention.

“We need also to commit to using antimicrobials in animals prudently and responsibly. This also goes hand-in-hand with vaccination strategies, farm biosecurity strengthening, good animal husbandry practices, because all these work together to reduce the need for antimicrobials — and when we need them, then let’s use them prudently and responsibly.”

Lwoyero warned that the human health consequences of AMR could not be separated from what happens on farms, in food production systems and in the environment.

“When we protect human health, it does not only start when they are at the clinic. This protection starts with stronger animal health systems, because these assure us that the animals will be healthy, the food from these animals will be healthy, and therefore people interacting with the animals and with the food from the animals will also be healthy.”

Meanwhile, Chairperson of the Global AMR Media Alliance (GAMA), Shobha Shukla, said the threat of drug resistance was much closer to everyday life than many people realised.

“A simple injury – a cut or a needle prick or any other such day-to-day accident - can put us at risk of getting infected with drug-resistant infections – which could be difficult to treat due to AMR or worse – incurable.

“This could happen to our lovely plants and animals too – and is polluting our environment – our mother Earth too. We need to save the medicines that protect us. We are talking about antibiotics, antifungals, antivirals and antiparasitics or other medicines. We need to stop misuse and overuse of medicines that fuels antimicrobial resistance. And most importantly, we need to ensure no one gets infected with preventable infectious diseases.”

Shukla said the 2026 World AMR Awareness Week, observed globally from November 18 to 24, themed: “One Health, one action: Prevent AMR now,” focuses on AMR remaining among the world's top 10 global health threats and posing serious danger to food security, hence  priority must shift from simply encouraging countries to develop national action plans to ensuring they have the capacity to implement them.

“The central challenge is no longer simply getting countries to recognise AMR or develop national action plans. It is ensuring that countries have the funding, surveillance systems, laboratory capacity, effective interventions and accountability mechanisms to implement them.”

She said the updated Global Action Plan offers an opportunity to strengthen prevention-first interventions, promote sustainable agrifood systems, address environmental drivers of resistance and improve national accountability but cautioned that efforts to curb inappropriate antimicrobial use must not deprive patients who genuinely need these medicines of access to effective treatment.

“Countries responses must balance preventing unnecessary antimicrobial use while ensuring people who genuinely need effective medicines can obtain them. A multi-sectoral response under the One Health banner is warranted to prevent AMR. Equally important is to humanize AMR response at all levels in a person-centred, rights-based and gender transformative manner.”


Immunisation: Stakeholders move to sustain BOOST gains in Lagos, Kano States

By Admin With donor-supported health interventions often facing sustainability questions after project f...